These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17184863)

  • 21. Optimal treatment for in-stent restenosis after BMS--DES, coated balloon, or scalpel?
    Mukherjee D
    Eur Heart J; 2008 Jul; 29(13):1595-6. PubMed ID: 18556717
    [No Abstract]   [Full Text] [Related]  

  • 22. Paclitaxel-eluting balloon: from bench to bed.
    De Labriolle A; Pakala R; Bonello L; Lemesle G; Scheinowitz M; Waksman R
    Catheter Cardiovasc Interv; 2009 Apr; 73(5):643-52. PubMed ID: 19309715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brachytherapy two years out.
    SoRelle R
    Circulation; 2002 Jul; 106(5):e9009. PubMed ID: 12147555
    [No Abstract]   [Full Text] [Related]  

  • 24. Is team management appropriate for a patient receiving coronary brachytherapy?
    Jhingran A
    Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):3. PubMed ID: 12909206
    [No Abstract]   [Full Text] [Related]  

  • 25. Enhanced level of micronuclei in peripheral blood lymphocytes of patients treated for restenosis with 32P endovascular brachytherapy.
    Wojcik A; Buraczewska I; Sommer S; Brzozowska K; Pregowski J; Witkowski A; Garmol D; Pszona S; Bulski W
    Cardiovasc Revasc Med; 2008; 9(3):149-55. PubMed ID: 18606378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interpreting the music of drug-eluting stents: halcyon song or albatross dirge?
    Mark DB
    J Am Coll Cardiol; 2008 May; 51(19):1854-6. PubMed ID: 18466799
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-term outcomes after intracoronary Beta-irradiation for in-stent restenosis in bare-metal stents.
    Maeder MT; Pfisterer ME; Buser PT; Roser HW; Roth J; Weilenmann D; Nietlispach FP; Zellweger MJ; Amsler B; Kaiser CA
    J Invasive Cardiol; 2008 Apr; 20(4):179-84. PubMed ID: 18398235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Too late, too complex, but.
    Bonan R
    J Invasive Cardiol; 2006 Sep; 18(9):440. PubMed ID: 16954588
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
    Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-Stent Restenosis: Treatment Controversies. May 14-16, 2002.
    J Invasive Cardiol; 2002 Oct; 14 Suppl D():1D-15D. PubMed ID: 12405115
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy and safety of absorbable metallic stents with adjunct intracoronary beta radiation in porcine coronary arteries.
    Waksman R; Pakala R; Okabe T; Hellinga D; Chan R; Tio MO; Wittchow E; Hartwig S; Waldmann KH; Harder C
    J Interv Cardiol; 2007 Oct; 20(5):367-72. PubMed ID: 17880333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-energy gamma-emitting stents inhibit intimal hyperplasia with minimal "edge effects" in a pig coronary artery model.
    Kutryk MJ; Kuliszewski MA; Jaffe R; Tio FO; Janicki C; Sweet WL; Sparkes JD; Strauss BH
    Cardiovasc Revasc Med; 2007; 8(1):28-37. PubMed ID: 17293266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of drug-eluting stent restenosis.
    Costa MA
    Am Heart J; 2007 Apr; 153(4):447-9. PubMed ID: 17383277
    [No Abstract]   [Full Text] [Related]  

  • 34. Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial.
    Ellis SG; O'Shaughnessy CD; Martin SL; Kent K; McGarry T; Turco MA; Kereiakes DJ; Popma JJ; Friedman M; Koglin J; Stone GW;
    Eur Heart J; 2008 Jul; 29(13):1625-34. PubMed ID: 18556716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Image-based brachytherapy: a forum for collaboration between radiation oncologists and diagnostic radiologists.
    Erickson B
    J Am Coll Radiol; 2005 Sep; 2(9):753-8. PubMed ID: 17411923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nf-kappab and AP-1 activation is associated with late lumen loss after porcine coronary angioplasty and antiproliferative beta-irradiation.
    Deiner C; Shagdarsuren E; Schwimmbeck PL; Rosenthal P; Loddenkemper C; Rauch U; Pauschinger M; Dietz R; Schultheiss HP; Dechend R; Pels K
    Cardiovasc Res; 2007 Jul; 75(1):195-204. PubMed ID: 17434466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A look at drug eluting stents with optical coherence tomography.
    de Smet BJ; Zijlstra F
    Eur Heart J; 2007 Apr; 28(8):918-9. PubMed ID: 17347174
    [No Abstract]   [Full Text] [Related]  

  • 38. [Progress on reasech of drug-coated stent].
    Zhang L; Liu J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Feb; 24(1):235-9. PubMed ID: 17333930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta endovascular brachytherapy using CO2-filled centering catheter for treatment of recurrent superficial femoropopliteal artery disease.
    Pokrajac B; Kirisits C; Schmid R; Schillinger M; Berger D; Peer K; Tripuraneni P; Pötter R; Minar E
    Cardiovasc Revasc Med; 2009; 10(3):162-5. PubMed ID: 19595397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of restenosis with a paclitaxel-coated balloon catheter.
    Agostoni P; Sangiorgi GM; Biondi-Zoccai GG
    N Engl J Med; 2007 Mar; 356(10):1071-2; author reply 1072-3. PubMed ID: 17354308
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.